510(k) Report

510(k) · Cleared

Cleared

Reaxon Plus

K180222510(k) TraditionalCleared Apr 24, 201889-day reviewClass II21 CFR 882.5275

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medovent GmbH · JXI Cuff, Nerve

Cleared on Apr 24, 2018 as substantially equivalent to K011168 (Integra Lifesciences Corp., 2001) after an 89-day review. Its family tree reaches back 1 generation to 2001.

Decided
Apr 24, 2018
Review
89 days
Class
Class II
Product code
JXI
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K011168 (2001). No later device cites it as a predicate yet.

K011168 · Neurogen Nerve Guide · Integra Lifesciences Corp. · 2001 · recalled20002005201020152020
  1. Root · 1 generation backK011168 Neurogen Nerve GuideIntegra Lifesciences Corp. · 2001 · Recalled
  2. This deviceK180222 Reaxon PlusMedovent GmbH · 2018
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K011168Neurogen Nerve GuideIntegra Lifesciences Corp.20012
0 (this device)K180222Reaxon PlusMedovent GmbH2018—
FIG. 1 — Lineage of K180222, 2001–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JXI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JXI device

  1. #1 K232029 VersaWrap Nerve Protectorscore 12.6 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K011168Neurogen Nerve Guide
Summary page 6
…uide Company Name Medovent GmbH Integra LifeSciences Corporation 510(k) # K180222 K011168 Material Chitosan Collagen Indications For Use Repair of periphera…
Integra Lifesciences Corp.20012

Also cleared against K011168: 8 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has a recall.
  • 8 other devices also cite its predicate K011168.

How does its category compare?

All JXI devices

JXI Cuff, Nerve: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · JXI

4in 2025

2010: 12011: 12012: 12014: 32015: 12016: 32017: 32018: 12019: 12020: 12022: 22023: 32024: 32025: 42026 (partial year): 2
2007high 4 (2025) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JXI

99in 2025

2014: 309 days median2016: 117 days median2017: 90 days median2023: 122 days median2024: 266 days median2025: 99 days median
2007high 309 (2014) · low 90 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JXI

No recall names JXI since 2007.

Adverse event reports per year · JXI

18in 2025

2008: 72009: 72010: 82011: 112013: 72014: 72015: 52016: 82017: 92018: 62019: 102020: 52021: 32022: 82023: 152024: 182025: 18
2007high 18 (2024) · low 0 (2007)2025

MAUDE reports naming product code JXI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—07
20090—07
20101—08
20111—011
20121—00
20130—07
2014330907
20151—05
2016311708
201739009
20181—06
20191—010
20201—05
20210—03
20222—08
20233122015
20243266018
2025499018
20262—0—

What is it indicated for?

Reaxon Plus is indicated for repair of peripheral nerve discontinuities where gap closure can be achieved by flexion of the extremity.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K180222: Reaxon Plus.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K180222

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026